In vivo PEG modification of vascular surfaces for targeted delivery
- 1 April 2012
- journal article
- research article
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 55 (4) , 1087-1095
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Optimization of ultrasound contrast agents with computational models to improve selection of ligands and binding strengthBiotechnology and Bioengineering, 2010
- Correlation of Intravascular Ultrasound Findings With Histopathological Analysis of Thrombus Aspirates in Patients With Very Late Drug-Eluting Stent ThrombosisCirculation, 2009
- Polymer stent coating for prevention of neointimal hyperplasia.2006
- Targeted delivery of heparin and LMWH using a fibrin antibody prevents restenosisAtherosclerosis, 2004
- In Vivo US Monitoring of Catheter-based Vascular Delivery of Gene Microspheres in Pigs: FeasibilityRadiology, 2003
- Inflammation and Restenosis in the Stent EraArteriosclerosis, Thrombosis, and Vascular Biology, 2002
- Chemistry for peptide and protein PEGylationAdvanced Drug Delivery Reviews, 2002
- Effect of resveratrol on intimal hyperplasia after endothelial denudation in an experimental rabbit modelLife Sciences, 2000
- Nitric oxide-generating polymers reduce platelet adhesion and smooth muscle cell proliferationBiomaterials, 2000
- Molecular barriers to biomaterial thrombosis by modification of surface proteins with polyethylene glycolBiomaterials, 1998